Pathologic Processes Clinical Trials

7 recruitingLast updated: June 17, 2026

There are 7 actively recruiting pathologic processes clinical trials across 9 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4. Top locations include Benin City, Nigeria, Bhubaneswar, India, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Pathologic Processes Trials at a Glance

7 actively recruiting trials for pathologic processes are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Benin City, Bhubaneswar, and Boston. Lead sponsors running pathologic processes studies include C5 Biomedical, EP Plus Group Sdn Bhd, and Brigham and Women's Hospital.

Browse pathologic processes trials by phase

Treatments under study

About Pathologic Processes Clinical Trials

Looking for clinical trials for Pathologic Processes? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pathologic Processes trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pathologic Processes clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Testing VIRTUES Patient Care Sets in Cardiac Patients (VIRTUES Cardiac Care)

Cardiovascular DiseasesAtrial FibrillationArrhythmias, Cardiac+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2,000 enrolled1 locationNCT05452356
Recruiting
Phase 4

Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome

Pathologic ProcessesIntestinal DiseaseGastrointestinal Diseases+5 more
EP Plus Group Sdn Bhd60 enrolled1 locationNCT06271538
Recruiting
Not Applicable

Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens

Lung CancerLymph Node MetastasisPathologic Processes
Brigham and Women's Hospital160 enrolled1 locationNCT06252129
Recruiting
Phase 3

Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery

Surgical wound infectionAnesthesiaPathologic Processes+9 more
University of Birmingham12,942 enrolled37 locationsNCT04256798
Recruiting
Not Applicable

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

Diabetes MellitusCardiovascular DiseasesDiabetes Mellitus, Type 2+16 more
C5 Biomedical177 enrolled1 locationNCT06674980
Recruiting
Phase 2

Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock

SepsisPathologic ProcessesInfections+4 more
Ottawa Hospital Research Institute296 enrolled2 locationsNCT05969275
Recruiting
Not Applicable

Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis

Pathologic ProcessesMultiple SclerosisAutoimmune Diseases+3 more
Sheffield Teaching Hospitals NHS Foundation Trust24 enrolled1 locationNCT04786821